Shopify Inc. (SHOP)

Ligand Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	1,542	1,498	1,413	1,649	2,503	2,704
Short-Term Investments	4,278	4,016	3,626	3,438	5,287	3,694
Cash & Short-Term Investments	5,820	5,514	5,039	5,087	7,790	6,397
Cash Growth	15.91%	9.43%	-0.94%	-34.70%	21.76%	159.21%
Accounts Receivable	264	252	194	203	127.14	63.52
Other Receivables	106	122	98	75	70.1	114.12
Receivables	1,676	1,395	964	487	266.93	218.52
Inventory	-	26	19	-	-	-
Prepaid Expenses	-	59	55	48	49.92	25.05
Other Current Assets	505	260	198	428	432.84	236.84
Total Current Assets	8,001	7,254	6,275	6,050	8,539	6,878
Property, Plant & Equipment	143	140	147	486	301.91	211.48
Long-Term Investments	5,831	5,998	4,377	1,954	3,956	173.45
Goodwill	491	452	427	1,836	356.53	311.87
Other Intangible Assets	36	22	29	390	138.5	135.68
Long-Term Deferred Tax Assets	31	37	44	41	48.37	52.68
Other Long-Term Assets	25	21	-	-	-	-
Total Assets	14,561	13,924	11,299	10,757	13,340	7,763
Accounts Payable	839	360	364	364	284.01	168.72
Accrued Expenses	-	220	128	115	138.09	115.99
Current Portion of Long-Term Debt	919	918	-	-	-	-
Current Portion of Leases	20	18	17	18	15.75	10.05
Current Income Taxes Payable	-	58	18	9	13.51	19.68
Current Unearned Revenue	298	283	302	296	216.79	107.81
Other Current Liabilities	2	99	69	54	34.59	16.09
Total Current Liabilities	2,078	1,956	898	856	702.73	438.33
Long-Term Debt	-	-	916	913	910.96	758.01
Long-Term Leases	200	190	217	465	246.78	144.84
Long-Term Unearned Revenue	123	147	196	268	162.93	21.01
Long-Term Deferred Tax Liabilities	36	73	6	16	183.43	-
Total Liabilities	2,437	2,366	2,233	2,518	2,207	1,362
Common Stock	9,985	9,634	9,201	8,747	8,040	6,115
Additional Paid-In Capital	281	305	251	30	161.07	261.44
Retained Earnings	1,853	1,629	-390	-522	2,938	15.29
Comprehensive Income & Other	5	-10	4	-16	-5.97	8.77
Total Common Equity	12,124	11,558	9,066	8,239	11,133	6,401
Shareholders' Equity	12,124	11,558	9,066	8,239	11,133	6,401
Total Liabilities & Equity	14,561	13,924	11,299	10,757	13,340	7,763
Total Debt	1,139	1,126	1,150	1,396	1,173	912.9
Net Cash (Debt)	5,512	5,097	4,004	3,691	6,616	5,484
Net Cash Growth	41.92%	27.30%	8.48%	-44.21%	20.64%	136.77%
Net Cash Per Share	4.20	3.92	3.09	2.91	5.19	4.44
Filing Date Shares Outstanding	1,300	1,295	1,287	1,277	1,260	1,226
Total Common Shares Outstanding	1,299	1,295	1,287	1,275	1,260	1,225
Working Capital	5,923	5,298	5,377	5,194	7,837	6,439
Book Value Per Share	9.33	8.93	7.05	6.46	8.84	5.22
Tangible Book Value	11,597	11,084	8,610	6,013	10,638	5,953
Tangible Book Value Per Share	8.93	8.56	6.69	4.72	8.45	4.86
Machinery	-	68	63	102	73.74	60.52
Leasehold Improvements	-	149	142	182	159.13	131.2

Updated Aug 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q